Former Judge Andrew Napolitano told Newsmax on Thursday that Luigi Mangione, the man accused of killing UnitedHealthcare CEO Brian Thompson, could face the death penalty if federal prosecutors pursue charges of murder as an act of terrorism.
The U.S. Supreme Court agreed on Wednesday to hear a case regarding whether South Carolina can eliminate Medicaid funding for Planned Parenthood clinics due to their provision of abortion services.
Healthcare spending in the United States surged by 7.5% to $4.9 trillion in 2023, driven by increased medical service use and rising enrollment in private health plans, according to a report from the Centers for Medicare and Medicaid Services (CMS).
Robert F. Kennedy Jr., President-elect Donald Trump’s nominee for Secretary of Health and Human Services, earned approximately $10.7 million in 2023, with much of his income stemming from his work with various law firms and his leadership of a vaccine-skeptic nonprofit. According to recently amended financial disclosures filed as part of his presidential campaign, Kennedy also holds significant assets, including between $500,001 and $1 million in Bitcoin and commercial real estate in Chicago worth hundreds of thousands of dollars.
Kentucky Governor Andy Beshear (D) firmly rejected calls for state funding of sex change operations for transgender inmates, emphasizing the need to prioritize law-abiding citizens over convicted felons.
Left-wing filmmaker Michael Moore sparked controversy by defending the anger directed at the health care industry following the assassination of UnitedHealthcare CEO Brian Thompson.
FBI agents conducted raids Thursday morning at autism treatment centers in Minneapolis and St. Cloud as part of a widening investigation into alleged Medicaid fraud.
House Speaker Mike Johnson (R-LA) is preparing to unveil a government spending bill that could include key components of President-elect Donald Trump’s healthcare agenda. Among the priorities under consideration is reforming Pharmacy Benefit Manager (PBM) practices, a move aimed at lowering prescription drug costs for seniors by tackling middleman-driven price inflation.
